Good find MJ.
Mike da Gama immediately follows Rob who is on the MDR Advisory Board.
Mr. Mike da Gama MBA, BSC, GAICD Executive Director of NostraData
Mr. da Gama is a highly valuable pharmaceutical industry and data analysis expert who will lead MedAdvisor’s penetration into multiple revenue generating channels. He brings expert sales and marketing experience from GlaxoSmithKline Australia and Arrow Pharmaceuticals.
Mr. da Gama is currently an Executive Director of NostraData, one of Australia’s leading data and insights providers used by over 60% of Australian pharmacies, providing dispensary and point of sale insights.
Pharmacy Connect 2017, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
